Skip to search formSkip to main contentSkip to account menu

relcovaptan

Known as: 1-(5-Chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxybenzenesulfonyl)-3-hydroxy-2,3-dihydro-1H-indole-2-carbonyl)pyrrolidine-2-carboxamide 
A substance being studied in the treatment of cancer. It inhibits a hormone growth factor that causes some cancer cells to divide. It is a type of… 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (4)

Hormone AntagonistsIndolesPlatelet Aggregation InhibitorsPyrrolidines

Narrower (1)

SR 49059

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract A063: Preclinical evaluation of an arginine vasopressin receptor 1A (AVPR1A) antagonist in castration-resistant prostate cancer
Background: Advanced prostate cancer is treated by androgen deprivation, but despite initial responses most tumors inevitably… 
Review
2009
Review
2009
New topics in vasopressin receptors and approach to novel drugs: preface.
Arginine vasopressin (AVP) is a cyclic nonapeptide that is centrally synthesized in the hypothalamus. Vasopressin has a plethora… 
Review
2008
Review
2008
[Pharmacology and clinical relevance of vasopressin antagonists].
As vasopressin receptors are found in many different tissues, vasopressin antagonists may benefit the treatment of numerous… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)